Explore By Subject Area   

Regeneron’s Approach to Strategic Collaborations, Licensing and Business Development

Nouhad Husseini, Regeneron Pharmaceutical, discusses  Regeneron’s approach to strategic collaborations, licensing and business development.

January 12, 2023
Regeneron’s Approach to Strategic Collaborations, Licensing and Business Development

Summary:

In this podcast, you will hear an executive fireside discussion with Nouhad Husseini, Regeneron Pharmaceuticals, and Allan Shaw, Portage Biotech /Shaw Strategic Capital, LLC from the 2022 Immuno-Oncology 360° Conference regarding Regeneron’s Approach to Strategic Collaborations, Licensing and Business Development.


To learn more about the Immuno-Oncology 360° Summit, please visit IO360Summit.com.

Speakers

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.